Puri Michal Nath
SEC CIK 1997032 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | CHRO | 203.2K | — | $102.7K | 13 | 2023-10-31 | 2026-06-30 |
Most active insiders at NVCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DOYLE WILLIAM F | Executive COB, Dir | — | $933.1K |
| 2 | Leonard Frank X | EVP, Pres, Novocure Oncology | — | $919.8K |
| 3 | Paravasthu Mukund | COO | — | $693.8K |
| 4 | Weinberg Uri | Chf Medical, Innovation Ofr | — | $232.2K |
| 5 | Brackmann Christoph | CFO | — | $85.3K |
| 6 | Stafford Kristin | Dir | — | $46.4K |
| 7 | Ocean Allyson J | Dir | — | $46.4K |
| 8 | Scannell Timothy J | Dir | — | $46.4K |
| 9 | VERNON W ANTHONY | Dir | — | $46.4K |
| 10 | Hung David | Dir | — | $46.4K |
| 13 | Puri Michal Nath | CHRO | — | $34.3K |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-01 16:33 | 2026-06-30 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | A - Grant | $11.15 | +1,905 | 203.2K | +0.9% | +$21.2K | |
| D | 2026-03-05 | 2026-03-03 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | A - Grant | $0.00 | +40.1K | 202.4K | +25% | $0 |
| D | 2026-03-05 | 2026-03-04 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | S - Sale | $13.31 | -1,100 | 201.3K | -0.5% | -$14.6K |
| 2026-03-03 | 2026-02-27 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | S - Sale | $13.66 | -1,441 | 162.3K | -0.9% | -$19.7K | |
| 2025-11-04 | 2025-10-31 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | F - Tax | $12.82 | -752 | 163.8K | -0.5% | -$9,641 | |
| 2025-07-01 | 2025-06-30 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | A - Grant | $15.13 | +833 | 164.5K | +0.5% | +$12.6K | |
| D | 2025-03-06 | 2025-03-04 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | A - Grant | $18.19 | +55.0K | 163.7K | +51% | +$1000.0K |
| MA | 2025-03-03 | 2025-02-27 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | S - Sale | $20.02 | -1,387 | 108.9K | -1% | -$27.8K |
| M | 2025-03-03 | 2025-02-27 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | S - Sale | $20.02 | -1,387 | 108.9K | -1% | -$27.8K |
| 2024-11-04 | 2024-10-31 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | S - Sale | $15.79 | -810 | 110.1K | -0.7% | -$12.8K | |
| 2024-08-06 | 2024-06-28 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | A - Grant | $12.24 | +1,736 | 110.9K | +2% | +$21.2K | |
| D | 2024-02-29 | 2024-02-27 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | A - Grant | $16.30 | +71.6K | 109.2K | +190% | +$1.17M |
| D | 2023-11-03 | 2023-10-31 | NVCR | NovoCure Ltd | Puri Michal Nath | CHRO | A - Grant | $0.00 | +37.6K | 37.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations